Summary & Overview
HCPCS Level II J0618: Injection, Calcium Chloride 2 mg
HCPCS Level II code J0618 denotes an injection of calcium chloride, 2 mg, used for parenteral calcium replacement and acute repletion. This code captures a specific injectable drug product and is relevant for hospital and clinic billing where intravenous or intramuscular administration is performed. Nationally, accurate reporting of drug J-codes like J0618 matters for medication safety, inventory management, and claims processing across payers.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna, UnitedHealthcare, and Medicare. Readers will find a concise presentation of what the code represents, the clinical context for its use, and the common sites of service where it is billed. The publication outlines typical billing considerations including common modifiers (listed separately), payer coverage patterns, and related policy considerations that affect reimbursement and coding practice.
The report provides benchmarks where available, highlights relevant policy updates affecting HCPCS drug coding and billing, and summarizes clinical contexts in which calcium chloride injection is administered. Data not available in the input will be noted explicitly in the appropriate sections.
Billing Code Overview
HCPCS Level II code J0618 represents an injection of calcium chloride, 2 mg. The service is an injectable medication administration intended for conditions requiring intravenous or intramuscular calcium replacement or acute calcium repletion. The service type is medication administration for injectable therapy. The typical site of service is hospital inpatient or outpatient settings, emergency departments, or other clinical settings where parenteral medications are administered.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical scenario involves an adult patient in an emergency department, inpatient unit, or monitored outpatient infusion center who requires rapid correction of severe hypocalcemia or acute symptomatic hypocalcemia (for example, tetany, perioral numbness, neuromuscular irritability, or unstable cardiac arrhythmia associated with low serum calcium). The clinician orders intravenous J0618 (injection, calcium chloride, 2 mg) when immediate parenteral calcium replacement is indicated and calcium chloride is preferred for faster delivery of ionized calcium, especially when central venous access is available due to its potential for local tissue injury if extravasation occurs. Typical workflow: assessment of signs/symptoms and serum calcium, confirmation of indication and vascular access type, documentation of dose and route, administration by emergency physician, hospitalist, or critical care nurse, post-administration monitoring of cardiac rhythm and serum electrolytes, and documentation of response in the medical record. Use commonly aligns with ACLS protocols for calcium administration during specific toxicology cases (e.g., calcium channel blocker overdose) or profound hypocalcemia with ECG changes.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | Default/No modifier | Use when no specific modifier applies to the service. |
| | Increased procedural services | Use when the service required substantially greater work than typically required; document justification.